Boston University
Targeting endothelial dysfunction in systemic sclerosis: a comparison of current and emerging therapeutics
Abstract
dc:description.abstractSystemic sclerosis is an autoimmune connective tissue disorder that despite the development of new therapeutics, retains poor long-term outcomes. The progression of the disease involves various organ systems leading to the development of severe complications that deteriorate patient’s quality of life and survival rates. The pathogenesis of the disease is extraordinarily complex and arises from disruptions across multiple systems. Current research emphasizes the role of early initial endothelial injury in the manifestation of systemic sclerosis. Addressing endothelial dysfunction has been an appealing target for the development of new therapeutics. Specifically, research has focused on the endothelin-1 pathway, the nitric oxide pathway, and the prostacyclin pathway for developing new medications. This research has yielded endothelin-1 receptor antagonists, phosphodiesterase-5 inhibitors, guanylate cyclase stimulators, and prostacyclin analogues as the major classes of medications used to treat this disease. Current therapeutics prove effective in preventing and slowing further endothelial damage but offer little ability to reverse fibrosis related damage. Complications such as pulmonary arterial hypertension, digital ulcers, are Raynaud’s phenomenon are most directly addressed by endothelial targeted therapies. However, other complications such as interstitial lung disease are not addressed by these types of medications. Consequently, the current approach to treatment relies on combining therapies to target complications from multiple avenues. Efficacy of existing therapeutics are similar across the board, however patients may prove individually more receptive to certain therapies. Personalized care that addresses patient’s individual susceptibility through autoantibody and genetic analysis prove effective in achieving better prognoses.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Kassis, Zack
- Advisors dc:contributor.advisor
-
- Offner, Gwynneth D
- Symes, Karen
Subjects
dc:subject × 4Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53497